Ownership history in &PARTNERS · 5 quarters on record
This page tracks every 13F SEC filing in which &PARTNERS reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 5,526 | +937 | +20.4% | 0.00% | $459K | $83.11 |
| 2025 Q2 | REDUCED | 4,589 | -1,596 | -25.8% | 0.00% | $339K | $73.40 |
| 2025 Q1 | REDUCED | 6,185 | -840 | -12.0% | 0.00% | $338K | $114.22 |
| 2024 Q4 | REDUCED | 7,025 | -369 | -5.0% | 0.00% | $361K | $50.39 |
As of 2025 Q4 — sorted by position size